Discover
BHVN
Biohaven Ltd.
14.10
1 x 14.07
1 x 14.09
bid
ask
-
0.44
3.03%
01:42 PM
timesize
| Ytd | 24.89% | |
| 1y | 5.15% |
13.74
day range
14.54
7.48
52 week range
18.57
| Open | 14.06 | Prev Close | 14.54 | Low | 13.74 | High | 14.54 | Mkt Cap | 2.12B |
| Vol | 1.18M | Avg Vol | 2.85M | EPS | -5.67 | P/E | -2.48 | Forward P/E | -7.54 |
| Beta | 1.26 | Short Ratio | 5.16 | Inst. Own | 92.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 13.87 | 200-d Avg | 11.50 | 1yr Est | 22.93 |
| Income Statement | |||
| Operating Expenses | 130.43M | ||
| Research and Development Expense | 103.83M | ||
| Selling, General and Administrative Expense | 26.60M | ||
| Operating Income | -130.43M | ||
| Income Tax Expense | 272.00K | ||
| Net Income | -130.53M | ||
| Net Income Common Stock | -130.53M | ||
| Net Income Common Stock (USD) | -130.53M | ||
| Consolidated Income | -130.53M | ||
| Earnings per Basic Share | -0.88 | ||
| Earnings per Basic Share (USD) | -0.88 | ||
| Earnings per Diluted Share | -0.88 | ||
| Earning Before Interest & Taxes (EBIT) | -130.26M | ||
| Earning Before Interest & Taxes (USD) | -130.26M | ||
| Weighted Average Shares | 147.62M | ||
| Weighted Average Shares Diluted | 147.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 273.07M | ||
| Cash and Equivalents (USD) | 273.07M | ||
| Investments | 74.74M | ||
| Investments Current | 74.74M | ||
| Current Assets | 385.65M | ||
| Property, Plant & Equipment Net | 15.26M | ||
| Total Assets | 466.41M | ||
| Total Debt | 280.27M | ||
| Current Liabilities | 52.08M | ||
| Debt Non-Current | 280.27M | ||
| Total Liabilities | 336.91M | ||
| Accumulated Retained Earnings (Deficit) | -2.22B | ||
| Accumulated Other Comprehensive Income | 8.30M | ||
| Shareholders Equity | 129.50M | ||
| Shareholders Equity (USD) | 129.50M | ||
| Assets Non-Current | 80.76M | ||
| Total Debt (USD) | 280.27M | ||
| Goodwill and Intangible Assets | 19.79M | ||
| Liabilities Non-Current | 284.83M | ||
| Trade and Non-Trade Payables | 10.42M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.37M | ||
| Net Cash Flow from Financing | 179.02M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 44.33M | ||
| Issuance (Purchase) of Equity Shares | 179.02M | ||
| Net Cash Flow from Investing | 15.21M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 15.21M | ||
| Net Cash Flow from Operations | -149.92M | ||
| Effect of Exchange Rate Changes on Cash | 16.00K | ||
| Share Based Compensation | 28.29M | ||